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ABSTRACT: Current proposals for the catalytic mechanism of aspartic proteinases are largely based on
X-ray structures of bound oligopeptide inhibitors possessing nonhydrolyzable analogues of the scissile
peptide bond. However, the positions of protons on the catalytic aspartates and the ligand in these complexes
have not been determined with certainty. Thus, our objective was to locate crucial protons at the active
site of an inhibitor complex since this will have major implications for a detailed understanding of the
mechanism of action. We have demonstrated that high-resolution neutron diffraction data can be collected
from crystals of the fungal aspartic proteinase endothiapepsin bound to a transition state analogue (H261).
The neutron structure of the complex has been refined at a resolution of 2.1 Å to an R-factor of 23.5%
and an Rfree of 27.4%. This work represents the largest protein structure studied to date by neutron
crystallography at high resolution. The neutron data demonstrate that 49% of the main chain nitrogens
have exchanged their hydrogen atoms with D2O in the mother liquor. The majority of residues resisting
exchange are buried within core â-sheet regions of the molecule. The neutron maps confirm that the
protein has a number of buried ionized carboxylate groups which are likely to give the molecule a net
negative charge even at very low pH, thereby accounting for its low pI. The functional groups at the
catalytic center have clearly undergone H-D exchange despite being buried by the inhibitor occupying
the active site cleft. Most importantly, the data provide convincing evidence that Asp 215 is protonated
and that Asp 32 is the negatively charged residue in the transition state complex. This has an important
bearing on mechanistic proposals for this class of proteinase.
The aspartic proteinases are a family of enzymes involved
in a number of important biological processes (see ref 1 for
a review). In animals, the enzyme renin has a hypertensive
action through its role in the renin-angiotensin system. The
retroviral aspartic proteinases, such as the HIV proteinase,
are essential for maturation of the virus particle, and
inhibitors have a proven therapeutic record in the treatment
of AIDS. The lysosomal aspartic proteinase cathepsin D has
been implicated in tumorigenesis, and the stomach enzyme
pepsin plays a major physiological role in hydrolysis of acid-
denatured proteins. All enzymes in this class are inhibited
by the microbial peptide pepstatin which contains the unusual
amino acid statine.
Structure and Mechanism
Most eukaryotic aspartic proteinases are monomeric and
consist of a single chain of 330 amino acids which forms
two similar domains with the active site located between
them. In contrast, retroviral aspartic proteinases are dimeric,
consisting of two identical subunits, each roughly equivalent
to one domain of a eukaryotic aspartic proteinase. Accord-
ingly, the amino acid sequences of the eukaryotic enzymes
have signs of an internal repeat relating the two halves of
the molecule, their level of identity being greatest in the
vicinity of the active site which involves two conserved Asp-
Thr-Gly sequences (2). Hence, the eukaryotic aspartic
proteinases are thought to have evolved divergently from a
primitive dimeric enzyme (resembling the retroviral protein-
ase) by gene duplication and fusion. In all aspartic protein-
ases, the base of the active site cleft is made of â-strands
which contain the catalytic aspartate residues (Asp 32 and
215 in porcine pepsin). The side chains of the aspartates are
held in a coplanar arrangement and within hydrogen bonding
distance by an intricate arrangement of H-bonds involving
surrounding main chain and conserved side chain groups. A
solvent molecule is found between both aspartate carboxyls
in all native aspartic proteinase crystal structures and is
presumed to be a water molecule. This water, which is
hydrogen-bonded to both aspartate carboxyls, is thought to
take part in the catalytic mechanism (3). In numerous
chemical studies, the failure to trap covalently bound
substrate indicates that the reaction involves an intermediate
which binds noncovalently to the enzyme (4). NMR studies
using an inhibitor with a ketone analogue of the scissile
peptide bond (5) suggested that it binds to the enzyme in a
hydrated gem-diol form [>C(OH)2]. Thus, current proposals
for the catalytic mechanism (such as that shown in Figure
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1) invoke nucleophilic attack of the active site water molecule
on the scissile bond carbonyl generating a tetrahedral gem-
diol intermediate (6). The latter is stabilized by hydrogen
bonds with the enzyme’s active site aspartates. Studies of
kinetic isotope effects using HIV proteinase have led to
similar conclusions (7).
Recently, it has been shown that the yeast aspartic pro-
teinase saccharopepsin has a macromolecular inhibitor which
forms an R-helix occupying the enzyme’s active site cleft
(8). In contrast, short oligopeptide inhibitors of aspartic
proteinases bind in the active site in extended conformations
with up to 10 amino acids occupying the cleft. The best
synthetic inhibitors are those in which one or both of the
hydroxyl groups of the putative transition state are mimicked
(intermediate 2 in Figure 1). One hydroxyl binds by hydrogen
bonds to both of the catalytic aspartates in the same position
as the solvent molecule in the native enzyme, and most of
the transition state analogues (e.g., statine) mimic this group
alone. In contrast, fluoroketone analogues (-CO-CF2-)
mimic both hydroxyls of the putative intermediate since they
readily hydrate to the gem-diol form [-C(OH)2-CF2-].
In catalysis, the active site water molecule may become
partly displaced upon substrate binding and polarized by one
of the aspartate carboxyls (9). The water may then nucleo-
philically attack the scissile bond carbonyl group to form
the tetrahedral intermediate. The latest proposals for the
mechanism based on crystal structures (6, 9-11) are con-
sistent in general terms, but they lack direct experimental
evidence for the protonation states of the active site groups.
Since the active site hydrogen atoms cannot be located by
X-ray analysis of proteins even at high resolution, their
putative positions have to be inferred from the local geometry
of surrounding polar atoms. One of the key features of the
mechanism proposed by Veerapandian et al. (6) (shown in
Figure 1) is the stabilization of the transition state by a
negative charge localized on Asp 32. The assignment of a
negative charge to this residue was made on the basis that
its hydrogen bonding capacity is satisfied to a greater extent
than that of Asp 215 in complex with the gem-diol inhibitor.
This implies that a negative charge on Asp 32 would be more
stable than if it were on Asp 215 in the transition state
complex. However, the protonation states of the catalytic
aspartates in the complexes had not been determined with
certainty at that stage.
Background to Neutron Studies
Information about the location of hydrogen atoms in
proteins can be obtained from X-ray cryocrystallographic
studies if atomic resolution data can be collected (d < 1.2
Å). Hydrogen atom positions can be determined for particu-
larly well ordered regions of the main chain and side chains,
but disorder and high temperature factors can still render
many more labile hydrogen atoms invisible. In addition,
hydrogen atoms involved in low-barrier hydrogen bonds
(found at enzyme active sites) will be distributed between
two positions 0.5 Å apart (12) and may therefore have high
apparent temperature factors. There is evidence for these
effects in neutron studies of carboxylic acid dimers (13).
Recent work has shown that a number of functional groups
in proteins, including carboxylates, are particularly vulnerable
to radiolytic damage at the radiation doses that might be
required to collect such atomic resolution data from protein
crystals (14, 15). Aspartate and glutamate residues, including
those involved in buried salt bridge interactions, are found
to become disordered rapidly and appear to suffer from
decarboxylation of the side chain even at 100 K. These
effects could make the process of locating hydrogen atoms
on active site carboxylate groups with X-ray data difficult.
However, atomic resolution X-ray crystallography provides
an alternative means of defining the protonation states of
carboxylate groups. Neutral carboxyl groups have a signifi-
cant difference between the C-OH and CdO bond lengths
(typically, 1.20 Å for the CdO bond and 1.30 Å for the
C-OH bond), whereas ionized carboxylates are expected
to have identical C-O bond lengths (typically, 1.25 Å) due
to resonance. Thus, unrestrained refinement using atomic
resolution data is a very powerful tool for determination of
the protonation state of each residue and avoids the difficul-
ties of locating weak electron density due to the hydrogens
themselves (J. Helliwell, personal communication). However,
it must be remembered that the apparent bond lengths can
be influenced by the temperature factors of the atoms
involved. Unrestrained refinement of native endothiapepsin
at 0.9 Å (P. Erskine, unpublished observations) has shown
that one cannot assign a charge to either aspartate carboxyl
at the catalytic center since all four C-O bond lengths refine
to almost identical values. It is highly unlikely that both
aspartates are ionized at the same time in view of their
proximity. Therefore, this effect must be due to the presence
of two canonical forms at the catalytic center; i.e., in half of
the enzyme molecules Asp 32 is ionized, and in the
remaining half Asp 215 is ionized. However, an asymmetric
charge distribution may arise in the presence of substrate
(see Figure 1).
FIGURE 1: Catalytic mechanism proposed by Veerapandian et al.
(6) which is based on the X-ray structure of a difluoroketone (gem-
diol) inhibitor bound to endothiapepsin. A water molecule tightly
bound to the aspartates in the native enzyme is proposed to
nucleophilically attack the scissile bond carbonyl. The resulting
tetrahedral intermediate (2) is stabilized by hydrogen bonds to the
negatively charged carboxyl of Asp 32. Fission of the scissile C-N
bond is accompanied by transfer of a proton to the leaving amino
group either from Asp 215 (with nitrogen inversion) or from bulk
solvent. Dashed lines represent hydrogen bonds.
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Neutron protein crystallography offers a powerful adjunct
to X-ray analysis at the resolutions typical of most X-ray
protein structure determinations (d > 1.5 Å) by enabling key
details of hydrogen atom positions and solvent structure to
be revealed (16). Hydrogen and/or deuterium atoms may be
more readily located in a corresponding neutron analysis
because the scattering lengths of hydrogen (-3.7 fm) and
deuterium (6.7 fm) for neutrons are closely similar to those
of other biological atoms: 6.6 fm for carbon, 9.4 fm for
nitrogen, 5.8 fm for oxygen, and 2.8 fm for sulfur. The
difference in amplitude and phase means hydrogen atom
positions appear as characteristic negative density features
in neutron maps, while deuterium-labeled positions have
density indistinguishable from that of carbon atoms. Hydro-
gen- and deuterium-labeled or -exchanged positions can
therefore be distinguished in the crystal even at resolutions
of 2.0 Å. Nitrogen and oxygen atoms can also be dis-
tinguished, allowing the carbonyl and amides of asparagine
and glutamine residues to be properly assigned. While
cancellation of neighboring positive and negative scattering
density can reduce the visibility of some hydrogen-rich
groups in medium-resolution analyses [e.g., H2O (-1.7 fm)
and CH3 (-4.6 fm)], the opposite is true for deuterium-
labeled groups where strong reinforcement from neighboring
positively scattering atoms can greatly enhance their visibility
[e.g., D2O (19.1 fm) and CD3 (26.7 fm)]. This is particularly
important in D2O solvent structure analysis, where scattering
from both the deuterium and oxygen atoms can allow the
orientation and geometry of well-ordered water molecules
to be determined and can render disordered or mobile water
molecules more visible than in a corresponding X-ray
analysis.
Prior to exposure, crystals are usually subjected to H2O-
D2O exchange to reduce the otherwise large hydrogen
incoherent scattering background. This soaking procedure
enables all solvent accessible OH and NH groups on the
protein to undergo H-D exchange. Since neutron maps
readily discriminate between H and D density in the structure,
analysis of the pattern and extent of this H-D exchange can
provide an elegant probe of group accessibility, mobility,
and the dynamics of the protein.
The ability to visualize and discriminate individual hy-
drogen atoms, and more especially the deuterium isotope,
at resolutions of >1.5 Å and at room temperature is of much
potential value in the study of enzymatic processes. The use
of neutron diffraction in understanding enzyme mechanisms
at these resolutions was pioneered by Kossiakoff and Spencer
(17), whose analysis of trypsin contributed significantly to
the current understanding of serine proteinase catalysis.
Similar work on lysozyme (18) and ribonuclease (19) has
established the protonation states of the catalytic groups with
important implications for their mechanisms of action.
Despite this potential wealth of information, the problems
associated with the relatively low flux of available neutron
beams have until now restricted neutron crystallography to
only a few proteins which produce very large crystals. While
neutron analysis imparts no observable radiation damage
upon biological samples, the long time scales required to
collect data by conventional means have made most studies
prohibitive. To address these issues, a neutron Laue diffrac-
tometer (LADI) for protein crystallography was developed
by the EMBL Grenoble Outstation and the Institut Laue-
Langevin (ILL) (20). One of the benefits of the LADI
diffractometer is the speed with which high-resolution
neutron data can be collected. The combination of a broad
band-pass quasi-Laue geometry (e.g., ì ) 3.5 Å, dì/ì )
25%) with a novel cylindrical, neutron sensitive image plate
detector that completely surrounds the sample provides 10-
100-fold gains in efficiency compared with those of con-
ventional monochromatic neutron diffractometers (21). This
has made feasible studies of larger biological complexes and
smaller crystals than was previously possible and has enabled
the location of important hydrogen and/or deuterium atom
positions in a number of systems at the resolutions typical
of the majority of protein structure analyses (22-25). This
approach therefore offers great promise in the study and
location of key hydrogen atom positions involved in enzy-
matic mechanisms, proton pumping, and shuttling processes
and in protein-ligand bonding interactions.
We have collected neutron Laue data on an inhibitor
complex of the fungal aspartic proteinase endothiapepsin,
allowing the structure to be refined at a resolution of 2.1 Å.
The bound inhibitor H261 possesses a hydroxyethylene
transition state analogue (see Figure 2). The neutron structure
of the endothiapepsin complex reveals the locations of crucial
protons at the active site with important implications for the
mechanism of action. The structure confirms earlier sugges-
tions that the low pI values of many aspartic proteinases can
be attributed to buried negatively charged carboxyl groups.
This work also represents the largest macromolecular neutron
structure to be analyzed to date.
EXPERIMENTAL PROCEDURES
Crystallization and Deuteration. The cocrystals of endo-
thiapepsin complexed with H261 were obtained by an adap-
tation of the native enzyme crystallization (26). This involved
adding a 10-fold molar excess of inhibitor to enzyme at a
concentration of 2.0 mg/mL in 100 mM sodium acetate
buffer at pH 4.5. Finely ground ammonium sulfate was added
until slight turbidity became apparent (55% saturation), at
which point the solution was Millipore filtered and, if
necessary, a few drops of acetone was added to clear any
remaining turbidity. Crystals generally grew after several
weeks. Those used for neutron diffraction had been stored
in mother liquor for a total of 11 years. To reduce the
contribution of the large incoherent neutron scattering cross
section of hydrogen to the experimental background, crystals
of the endothiapepsin-H261 complex were subjected to
hydrogen-deuterium exchange by vapor diffusion for several
months prior to data collection.
The H-D exchange involved mounting selected crystals
in large diameter capillaries and equilibrating against suc-
cessive changes of a 90% deuterated mother liquor solution
and, finally, against several changes of a 95% deuterated
FIGURE 2: Chemical structure of the inhibitor H261. The central
region of the inhibitor mimics a Leu-Val dipeptide. Here the
inhibitor possesses a hydroxyethylene transition state analogue.
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solution. This method has been shown to be effective in other
studies (24). The decision to use vapor diffusion rather than
soaking directly in D2O was made to avoid shocking the
crystals since only a few were large enough for neutron data
collection and they were 11 years old at the time of the
experiment.
Preliminary neutron analysis identified several crystals that
were suitable for neutron Laue data collection. Data collec-
tion was started with the intention of obtaining a complete
data set with a single crystal (1.8 mm  1.4 mm  1.4 mm).
A partial data set to 2.2 Å was collected in a preliminary
experiment (27); however, the crystal later dried out, and a
second crystal of similar volume (3 mm3) from the same
batch was used to complete the data set. Both crystals had
been deuterated for the same length of time, were monoclinic
(P21), and had the following unit cell dimensions: a ) 43.1
Å, b ) 75.7 Å, c ) 42.9 Å, and â ) 97.0°.
Data Collection and Processing. Quasi-neutron Laue data
were collected on the LADI instrument installed on end-
station LADI/T17 of cold neutron guide H142 at ILL (21).
The detector consists of a large Gd203 doped neutron sensitive
image plate (400 mm  800 mm) mounted on a cylindrical
camera (318 mm diameter) that completely encircles the
sample (20). A Ni/Ti multilayer wavelength selector was used
to select a narrow band-pass (dì/ì ) 25%) centered at 3.20
Å. This serves to reduce both the reflection overlap at the
detector and the incoherent neutron scattering background
that comes largely from unexchanged hydrogens in the
sample. A further benefit of using a narrow quasi-Laue band-
pass is that, since the proportion of energy-overlapped
(harmonic) reflections is dependent on the ratio dì/ì and is
independent of the size of unit cell, almost all reflections
(>99%) recorded on the LADI detector are singlets and thus
amenable to standard crystallographic analysis. The spectral
range was determined by time-of-flight techniques.
Data for the endothiapepsin-H261 complex were collected
at room temperature. A total of 61 frames were obtained
with a  separation of typically 8° and exposure times
between 22 and 32 h per frame. The observed diffraction
peaks were indexed and matched to a wavelength range of
2.7-3.6 Å and to a dmin of 1.95 Å using the program
LAUEGEN (28, 29). Integrated intensities were extracted
using the I/ó(I) method (30, 31) as implemented in the
program INTEGRATE. Data from groups of images were
scaled together and wavelength-normalized (to account for
the spectral distribution) using the program LAUESCALE.
Data recorded at wavelengths of <2.8 Å were in poor
agreement with the remainder of the data, most likely due
to the falloff in the spectral intensity distribution, and were
excluded from wavelength normalization calculations. Final
scaling and merging of the data frames were performed with
SCALA of the CCP4 suite (32).
Refinement. The coordinates of the endothiapepsin-H261
complex were obtained from the earlier X-ray analysis of
this complex at 1.6 Å resolution (33). Least-squares refine-
ment with the neutron data set was performed initially using
XPLOR (34) assuming the molecule to be fully hydroge-
nated. Inspection of the neutron density maps (2Fo - Fc and
Fo - Fc) using the program TURBO-FRODO (Bio-Graphics,
Marseille, France) allowed deuterium sites to be identified
and modeled into the structure. Refinement was then
switched to SHELX-97 (35) which allowed incorporation
of stereochemical restraints for the deuterated and modified
amino acids. Rfree was calculated from 5% of the reflection
data which were omitted from the least-squares calculations.
These rounds of refinement were interspersed with inspection
of the maps to locate extra sites of deuteration and solvent
molecules, including D2O sites. During graphical rebuilding,
the neutron structure of the complex was checked to ensure
that significant deviations from the room-temperature X-ray
structure of the same complex (33) had not occurred. During
refinement, the coordinates and isotropic B-factors for all
atoms, including the hydrogen and deuterium atoms, were
refined with stereochemical restraints. Deuterium sites at the
catalytic center were located by inspection of difference
Fourier maps weighted by the sigma-A method (36). In the
refinement, a working high-resolution cutoff of 2.1 Å was
applied since inclusion of data beyond this was found to raise
the refinement R-factor by several percent. This may stem
from the fact that the second of the two crystals did not
diffract quite as well as the first at high resolution. To test
the locations of the active site deuteriums, the structure was
refined with two different active site models involving the
D atoms in two canonical forms. The resulting difference
Fourier maps were inspected to assess the likelihood of each
model being correct. Finally, the occupancies of the catalytic
D atoms in both models were refined. The coordinates of
the preferred model and structure factors have been deposited
with the Protein Data Bank (code 1gkt).
RESULTS AND DISCUSSION
The final neutron data set for the H261 complex comprised
102 312 reflections where I > 2.0ó(I). These were reduced
to 13 738 unique reflections to 2.1 Å resolution with a
merging R-factor of 7.5% and a completeness of 84.5%. Full
statistics for the data processing and refinement are given
in Table 1. The structure contains 4674 protein atoms
(including hydrogens and deuteriums), 159 inhibitor atoms,
and 256 solvent sites; 41 of these solvent sites have well-
defined density for D2O molecules and were therefore
modeled as D2O. While it might be expected that more D2O
sites would have been apparent at this resolution, the majority
of solvent density peaks were spherical and could be refined
satisfactorily as O atoms as is usual in X-ray studies. The
neutron visibility of the deuterium atoms in solvent molecules
would be reduced if they have high temperature factors. H2O
molecules scatter neutrons very weakly due to cancellation
of the H and O scattering lengths which have opposite signs.
Thus, the solvent sites which appear to only have density
for the central O atom are likely to be orientationally
disordered D2O molecules. The majority of the well-defined
D2O molecules are close to the surface of the protein, and
some are partially buried within the protein.
The final neutron refinement R-factor is 23.5% (27.4%
for Rfree). These R values are slightly high in comparison
with the values expected for a refined X-ray structure at
comparable resolution. However, they are consistent with R
values obtained in other analyses which have used neutron
Laue data (22-25). The neutron structure superimposes very
well with the previously determined X-ray structure of this
complex (33); the rms deviation between the two is only
0.2 Å for all CR atoms. While deuterium sites in the protein
generally are very well defined by the map, the neutron
density for hydrogen atoms, which appear as negative
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features in the 2Fo - Fc map, was found to be weaker and
harder to interpret. However, this is to be expected since
the scattering amplitude of hydrogen is approximately half
that of deuterium in addition to being of opposite sign. For
this reason, CH2 and CH3 groups commonly have weak
density since the scattering lengths of the atoms involved
tend to cancel each other out.
Extent of Deuteration. While deuteration of the crystals
was undertaken primarily to reduce incoherent scatter from
bulk solvent, the neutron data show that the endothiapepsin
molecule itself has become extensively deuterated by the
vapor diffusion protocol. The low pH of the mother liquor
(pH 4.5) would not be favorable for H-D exchange of the
groups on the protein. Indeed, in NMR experiments, lowering
the pH is used to deliberately quench H-D exchange, for
example, in time-resolved studies of protein folding. How-
ever, the length of time involved in the H-D exchange of
the endothiapepsin crystals (2-3 months) appears to have
allowed it to proceed to a reasonable extent. The extent of
main chain deuteration is shown in Figure 3. The majority
of amino acids have become deuterated either in the side
chain or in the main chain with the exposed secondary
structure elements being the most affected. In total, 215 of
330 residues (65%) have undergone side chain and/or main
chain deuteration. In the backbone, a total of 161 main chain
amides (49%) have exchanged. The parts of the molecule
most protected from exchange are the buried â-strand
regions. In contrast, the strands which have become most
deuterated are generally those at the exposed edges of the
sheets. The majority of polar side chains have exchanged,
and in general, the loops and helical regions have exchanged
to a greater extent than the â-sheet regions. Although the
active site cleft is occupied by a tight-binding inhibitor, many
residues in the vicinity of the catalytic center and specificity
pockets of the enzyme have undergone H-D exchange. It
is perhaps surprising that the protein has not become
deuterated to a greater extent. However, it should be
remembered that the crystals have a low solvent content
(39%), and the efficacy of capillary vapor diffusion for H2O-
D2O exchange is not well characterized as yet.
Buried Carboxylates and the pI of the Enzyme. A number
of aspartic proteinases have pI values which are unusually
low; e.g., pepsin has a pI value of 2.0 (1). It has been
suggested that these low pI values are due to buried
carboxylate groups which remain deprotonated even at very
low pH. Evidence for this effect is provided by the neutron
data since there are a number of buried carboxylates which
appear to be deprotonated. In general, the carboxylate groups
of these residues interact with buried main chain >NH
groups or polar side chain atoms. While a number of these
make salt bridge interactions (i.e., they will not contribute
to the net charge of the molecule), some do not and instead
interact with neutral polar groups which may function to
stabilize the negative charge on the carboxylates. A definitive
example of a buried, negatively charged carboxylate is Asp
87 which is an almost completely conserved residue. The
Table 1: Neutron Data and Refinement Statistics for the
Endothiapepsin-H261 Complex
unit cell
a (Å) 43.1
b (Å) 75.7
c (Å) 42.9
â (deg) 97.0
space group P21
no. of crystals 2
entire data set
resolution range (Å) 100.0-2.1
Rmerge (%) 7.5
completeness (%) 84.5
multiplicity 3.4
mean I/ó(I) 5.4
outer shell
resolution range (Å) 2.2-2.1
Rmerge (%) 11.9
completeness (%) 72.6
multiplicity 2.4
mean I/ó(I) 1.7
refinement (preferred model)
resolution range (Å) 20.0-2.1
no. of reflections 13548
overall R-factor (%) 23.46
overall Rfree (%) 27.42
outer shell R-factor (%) 33.10
rmsd for bond lengths (Å) 0.009
rmsd for bond angle distances (Å) 0.014
rmsd for bumps (Å) 0.051
rmsd for chiral volumes (Å3) 0.027
rmsd for planes (Å) 0.023
no. of atoms in asymmetric unit
C 1569
N 379
O 772
S 2
H 2055
D 393
total 5170
FIGURE 3: Extent of main chain deuteration of the endothiapepsin
molecule in two orthogonal views. Yellow shows the regions which
have not exchanged, whereas those regions shown in blue are
segments where the amino acids have become deuterated in the
main chain. In each view, the inhibitor (H261) can be seen
occupying the active site cleft.
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side chain of this residue accepts hydrogen bonds from the
side chains of Tyr 56, Ser 61, and Thr 63 as well as the
main chain >NH group of Thr 88. The neutron density
clearly shows that these four groups are deuterated (Figure
4) which strongly indicates that the aspartate is negatively
charged. Of the residues making these interactions, the Ser
and Thr side chains are strongly conserved; the tyrosine
residue is also conserved but to a lesser extent.
Deuteration of the ActiVe Site Residues. The residues
forming the catalytic center of aspartic proteinases are two
strongly conserved Asp-Thr-Gly-Ser/Thr sequences. These
are provided by the two domains of the enzyme where they
associate to form the active site cleft. The two aspartate
carboxyls are involved in numerous hydrogen bonds which
keep them approximately coplanar. The outer oxygens of
the aspartate diad accept hydrogen bonds from the Ser/Thr
side chains in the above consensus sequence. It is clear from
inspection of the neutron maps that these Ser and Thr
residues (Ser 35 and Thr 218) have deuterated side chains
despite having very low solvent accessibility due to the
presence of the inhibitor in the active site. The refined
neutron structure and maps for the active site are shown in
Figure 5. Since the active site flap and the inhibitor help to
shield the catalytic residues from the surrounding solvent,
the fact that buried active site residues have become
deuterated may indicate that the network of hydrogen bonds
FIGURE 4: A 2Fo - Fc density map (cyan) for residues in the vicinity of Asp 87 contoured at 1.0 rms. The map shows that the groups
hydrogen bonding with the carboxyl of this residue are all deuterated, confirming that the aspartate is deprotonated. Deuterium atoms are
shown in purple, and dashed lines represent hydrogen bonds.
FIGURE 5: A 2Fo - Fc density map (cyan) for residues in the vicinity of the catalytic aspartates contoured at 1.2 rms. The active site
aspartate residues are shown in the middle with Asp 32 in the foreground and Asp 215 behind. The two residues which form hydrogen
bonds with the outer oxygens of the carboxyl diad (Ser 35 and Thr 218) are also shown with the hydrogen bonds represented as dashed
lines. The deuterium atoms are colored purple.
FIGURE 6: Possible proton (or deuterium) positions at the catalytic
center. These models were tested by refinement with the neutron
data. Model 1 assumes that Asp 32 is negatively charged, whereas
model 2 assumes that Asp 215 is the negatively charged residue.
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in the active site cleft provides a means of exchanging
protons with the bulk solvent.
Catalytic Protons. The inhibitor H261 possesses a hy-
droxyethylene analogue (-CHOH-CH2-) in place of the
scissile peptide bond (see Figure 2). This analogue mimics
one hydroxyl of the putative tetrahedral intermediate (see
Figure 1). X-ray structural studies of the complex of H261
with endothiapepsin (33) as well as many similar inhibitor
complexes at high resolution (37) showed that this hydroxyl
replaces the water molecule found at the catalytic center of
the native enzyme. The hydroxyl appears to form short
hydrogen bonds with the inner carboxyl oxygen of Asp 32
and the outer carboxyl oxygen of Asp 215, indicating that
protons or deuterons must reside between these atoms. This
would allow them to form hydrogen bonds in one of two
possible tautomeric forms shown in Figure 6. The other two
possible hydrogen bonds to the hydroxyl group involve the
outer carboxyl oxygen of Asp 32 and the inner oxygen of
Asp 215, but both have unfavorable geometry (e.g., donor-
acceptor distances that are too long). These findings were
FIGURE 7: Neutron density at the catalytic center. Asp 32 and 215 are shown along with the transition state isostere. (a) Original difference
density (Fo - Fc) in dark blue and red lines which correspond to 2.5 and -2.5 rms, respectively. The 2Fo - Fc density is shown in cyan
contoured at 1.2 rms. The regions of positive difference density between the aspartates and ligand strongly suggest that the inhibitor hydroxyl
has a D substituent oriented toward Asp 32 and that Asp 215 is deuterated on its outer carboxyl oxygen. The region of negative difference
density close to Asp 32 cannot be interpreted easily since a proton located here would not make hydrogen bonds with other groups. The
refined neutron density maps for active site models 1 and 2 are shown in panels b and c, respectively, with the same contour levels as
shown for panel a. Asp 32 and 215 are shown as is the hydroxyl of the transition state isostere. The deuterium atoms at the catalytic center
are shown as gray spheres. Some parts of the inhibitor appear to be without density, but this is only because a narrow slab of each map is
displayed for clarity. The best fit is provided by model 1, shown in panel b.
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confirmed by recent atomic resolution X-ray studies of the
same complex at 1.1 Å resolution (P. Erskine, unpublished
observations).
In the deuterated H261 complex, there is significant
evidence that residues in the immediate vicinity of the
catalytic center have undergone H-D exchange (see above).
A difference Fourier map for the structure without hydrogens
or deuteriums modeled at the catalytic center (Figure 7a)
shows positive difference density for deuterium atoms on
the inhibitor hydroxyl and the outer carboxyl of Asp 215.
Since the neutron difference density for the deuterium sites
at the catalytic center seemed to bridge the gaps between
the inhibitor and the aspartates, it was considered necessary
to investigate different possible locations for the deuteriums.
Therefore, the structure was refined using the two separate
models of the deuterium positions shown in Figure 6, and
the resulting maps were inspected. In model 1, Asp 32 is
treated as being negatively charged, whereas in model 2, Asp
215 is treated as the negatively charged aspartate. From
inspection of the initial neutron difference Fourier maps,
model 1 was considered to be the most likely scenario. In
the neutron refinement of these two models, the occupancies
of all atoms, including deuteriums, were fixed at unity. The
refined neutron maps (2Fo - Fc and Fo - Fc) for models 1
and 2 are shown in panels b and c of Figure 7, respectively.
From inspection of these maps, it is clear that model 1
provides a qualitatively better fit to the data. In contrast, the
deuterium atoms in model 2 are at nodes in the 2Fo - Fc
density, and a feature of positive difference density remains
close to the outer oxygen of Asp 215, indicating that this
residue is deuterated. These results suggest that Asp 215 is
protonated in the transition state complex which is in accord
with the earlier proposal for the catalytic mechanism based
on X-ray analysis at 2.0 Å resolution of a fluoroketone
inhibitor (6). In this mechanism, Asp 32 was designated as
the negatively charged aspartate in the transition state
complex since its hydrogen bonding capacity is better
satisfied than that of Asp 215.
Finally, refinement of the occupancies of just the active
site deuteriums was undertaken for the two models, and the
results are shown in Figure 8. The refined occupancies
indicate that model 1 is more consistent with the data than
model 2 which is in accord with our initial interpretation of
the original difference Fourier. This is also corroborated by
atomic resolution X-ray analysis of the H261 complex at
100 K in which the pattern of aspartate C-O bond lengths
obtained by unrestrained refinement is in accord with model
1 (P. Erskine, unpublished observations), although the protein
was not deuterated for this study. The ability of the neutron
Laue data to discriminate between the models indicates that
the data are of high quality. In accord with the recent findings
of other groups (38), our results suggest that this technique
will be of much value in other mechanistic studies.
The results of this study indicate that model 1 is the most
likely scenario since there are strong indications that Asp
215 is deuterated. However, it may be significant that
occupancy refinement with the neutron data does not
discriminate between models 1 and 2 as well as might be
hoped. This may reflect on properties of the catalytic diad
itself. The donor-acceptor distances for the hydrogen bonds
made between the inhibitor hydroxyl and the catalytic
aspartates are very short (2.6 Å). This was suggested by
many previous X-ray studies at 2.0 Å resolution (37) and
has recently been corroborated by the atomic resolution data
and NMR (L. Coates, P. Erskine, and M. P. Crump,
manuscript in preparation). The hydrogen bond involving
Asp 32 is consistently the shortest (<2.6 Å). Hydrogen bonds
as short at 2.5-2.6 Å are termed low-barrier hydrogen bonds
since the proximity of the donor and acceptor atoms reduces
the energy barrier which normally prevents transfer of the
hydrogen atom from the donor to the acceptor group (12).
Thus, rapid exchange of the proton between the donor and
acceptor atoms can occur, and this has been proposed as an
important effect in the catalytic mechanisms of a number of
enzymes, including citrate synthase and the serine protein-
ases. Thus, we propose that some of the difficulty in
determining the exact positions of the active site D atoms is
due to formation of a low-barrier hydrogen bond between
the hydroxyl of the inhibitor and the carboxyl of Asp 32.
While our neutron results indicate strongly that Asp 215 is
deuterated in the transition state analogue complex, the
formation of a low-barrier hydrogen bond between the
inhibitor hydroxyl and Asp 32 would tend to delocalize the
neutron density between these two groups. Atomic resolution
X-ray studies and NMR indicate that the short hydrogen
bonds are absent in the native structure where a water
molecule is bound to both carboxyls. In accord with studies
of the serine proteinases, this indicates that low-barrier
hydrogen bond formation is due to steric compression upon
inhibitor binding.
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